# Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma

> **NCT00002599** · PHASE3 · UNKNOWN · sponsor: **Medical Research Council** · enrollment: 750 (estimated)

## Conditions studied

- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** recombinant interferon alfa
- **BIOLOGICAL:** sargramostim
- **DRUG:** carmustine
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** melphalan
- **DRUG:** methylprednisolone
- **DRUG:** prednisone
- **DRUG:** vincristine sulfate
- **RADIATION:** low-LET cobalt-60 gamma ray therapy
- **RADIATION:** low-LET photon therapy

## Key facts

- **NCT ID:** NCT00002599
- **Lead sponsor:** Medical Research Council
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1994-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2013-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002599, "Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00002599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*